On April 5,2024, Archon Capital Management announced that it has engaged, and intend to continue to engage, in communications with the Apyx Medical Corporation?s Board of Directors and management team regarding means of increasing stockholder value at the Company, including by enhancing the Board through the addition of well-qualified directors.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.5 USD | -9.64% | +6.38% | -42.75% |
05-09 | Transcript : Apyx Medical Corporation, Q1 2024 Earnings Call, May 09, 2024 | |
05-09 | Stavros Vizirgianakis Enters into Letter Agreement with Apyx Medical | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-42.75% | 51.97M | |
-4.84% | 182B | |
+0.56% | 110B | |
-3.35% | 68.11B | |
+2.39% | 50.53B | |
+9.36% | 44.8B | |
+2.70% | 40.7B | |
+3.43% | 26.53B | |
+13.67% | 25.02B | |
-0.32% | 24.96B |
- Stock Market
- Equities
- APYX Stock
- News Apyx Medical Corporation
- Archon Capital Management Engages with Apyx Medical Corporation